20
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

The Prevalence and Characteristics of Employee Assistance, Health Promotion and Drug Testing Programs in Ontario

&
Pages 25-60 | Published online: 14 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Rick Csiernik, Scott Macdonald, Pierre Durand, T. Cameron Wild & Margaret Rylett. (2006) Who Do We Serve?. Journal of Workplace Behavioral Health 21:2, pages 15-29.
Read now
Scott Macdonald, Richard Csiernik, Pierre Durand, T. Cameron Wild, Stephen Dooley, Margaret Rylett, Samantha Wells & Jodi Sturge. (2006) Changes in the Prevalence and Characteristics of Ontario Workplace Health Programs. Journal of Workplace Behavioral Health 22:1, pages 53-64.
Read now
Scott Macdonald, Samantha Wells, Shelley Lothian & Martin Shain. (2000) Absenteeism and Other Workplace Indicators of Employee Assistance Program Clients and Matched Controls. Employee Assistance Quarterly 15:3, pages 41-57.
Read now
Scott Macdonald & Samantha Well. (1996) Lifestyle Problems and Health Programs in Ontario Worksectors. Employee Assistance Quarterly 11:2, pages 37-49.
Read now

Articles from other publishers (4)

Scott Macdonald, Richard Csiernik, Pierre Durand, Margaret Rylett & T. Cameron Wild. (2006) Prevalence and Factors Related to Canadian Workplace Health Programs. Canadian Journal of Public Health 97:2, pages 121-125.
Crossref
Scott Macdonald, Christine Bois, Bruna Brands, Diane Dempsey, Patricia Erickson, David Marsh, Stephen Meredith, Martin Shain, Wayne Skinner & Angelina Chiu. (2001) Drug testing and mandatory treatment for welfare recipients. International Journal of Drug Policy 12:3, pages 249-257.
Crossref
Scott Macdonald, Shelley Lothian & Samantha Wells. (1997) Evaluation of an employee assistance program at a transportation company. Evaluation and Program Planning 20:4, pages 495-505.
Crossref
Scott Macdonald. (1995) The Role of Drugs in Workplace Injuries: Is Drug Testing Appropriate?. Journal of Drug Issues 25:4, pages 703-722.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.